BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18853344)

  • 1. Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention.
    Peterson JM; Guttridge DC
    Int Rev Immunol; 2008; 27(5):375-87. PubMed ID: 18853344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch.
    Dogra C; Changotra H; Wergedal JE; Kumar A
    J Cell Physiol; 2006 Sep; 208(3):575-85. PubMed ID: 16741926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive nuclear factor-kappaB activation resistant to inhibition by contraction and curcumin in mdx mice.
    Durham WJ; Arbogast S; Gerken E; Li YP; Reid MB
    Muscle Nerve; 2006 Sep; 34(3):298-303. PubMed ID: 16718687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-kappaB signaling pathway and its therapeutic implications in human diseases.
    Sarkar FH; Li Y; Wang Z; Kong D
    Int Rev Immunol; 2008; 27(5):293-319. PubMed ID: 18853341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy.
    Haslbeck KM; Friess U; Schleicher ED; Bierhaus A; Nawroth PP; Kirchner A; Pauli E; Neundörfer B; Heuss D
    Acta Neuropathol; 2005 Sep; 110(3):247-54. PubMed ID: 15986224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of NF-kappaB signaling: 785 and counting.
    Gilmore TD; Herscovitch M
    Oncogene; 2006 Oct; 25(51):6887-99. PubMed ID: 17072334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of NF-kappaB transcriptional activity.
    Vermeulen L; Vanden Berghe W; Haegeman G
    Cancer Treat Res; 2006; 130():89-102. PubMed ID: 16610704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch1 upregulates LPS-induced macrophage activation by increasing NF-kappaB activity.
    Monsalve E; Ruiz-García A; Baladrón V; Ruiz-Hidalgo MJ; Sánchez-Solana B; Rivero S; García-Ramírez JJ; Rubio A; Laborda J; Díaz-Guerra MJ
    Eur J Immunol; 2009 Sep; 39(9):2556-70. PubMed ID: 19662631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells.
    Reuter S; Charlet J; Juncker T; Teiten MH; Dicato M; Diederich M
    Ann N Y Acad Sci; 2009 Aug; 1171():436-47. PubMed ID: 19723087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune deficiency or hyperactivity-Nf-kappab illuminates autoimmunity.
    Pai S; Thomas R
    J Autoimmun; 2008 Nov; 31(3):245-51. PubMed ID: 18539434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The I{kappa}B kinase {beta}/nuclear factor {kappa}B signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression.
    Hikoso S; Yamaguchi O; Nakano Y; Takeda T; Omiya S; Mizote I; Taneike M; Oka T; Tamai T; Oyabu J; Uno Y; Matsumura Y; Nishida K; Suzuki K; Kogo M; Hori M; Otsu K
    Circ Res; 2009 Jul; 105(1):70-9. PubMed ID: 19478205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic regulation of NF-kappaB signaling.
    Cummins EP; Comerford KM; Scholz C; Bruning U; Taylor CT
    Methods Enzymol; 2007; 435():479-92. PubMed ID: 17998070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks.
    Uwe S
    Biochem Pharmacol; 2008 Apr; 75(8):1567-79. PubMed ID: 18070616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-κB signaling in skeletal muscle health and disease.
    Peterson JM; Bakkar N; Guttridge DC
    Curr Top Dev Biol; 2011; 96():85-119. PubMed ID: 21621068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the TLR/NF-kappaB pathway in antigen-presenting cells in malignancies promoted by inflammation.
    Blander JM
    Methods Mol Biol; 2009; 512():99-117. PubMed ID: 19347275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear factor-kappaB: fine-tuning a central integrator of diverse biologic stimuli.
    Krakauer T
    Int Rev Immunol; 2008; 27(5):286-92. PubMed ID: 18853340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARgamma inhibits NF-kappaB-dependent transcriptional activation in skeletal muscle.
    Remels AH; Langen RC; Gosker HR; Russell AP; Spaapen F; Voncken JW; Schrauwen P; Schols AM
    Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E174-83. PubMed ID: 19417127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer.
    Fraser CC
    Int Rev Immunol; 2008; 27(5):320-50. PubMed ID: 18853342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis.
    Gareus R; Kotsaki E; Xanthoulea S; van der Made I; Gijbels MJ; Kardakaris R; Polykratis A; Kollias G; de Winther MP; Pasparakis M
    Cell Metab; 2008 Nov; 8(5):372-83. PubMed ID: 19046569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.